Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

5(55.6%)

Phase 2

2(22.2%)

Phase 3

1(11.1%)

Phase 4

1(11.1%)

9Total

N/A(5)

Phase 2(2)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07276360Phase 2Recruiting

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

Role: lead

NCT06212570Not ApplicableNot Yet Recruiting

KeyScope Study in Uganda

Role: collaborator

NCT06452004Not ApplicableActive Not Recruiting

Validation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC)

Role: collaborator

NCT03916783Not ApplicableWithdrawn

Suubi4Cancer: Improving Access to Pediatric Cancer Services and Treatment Adherence Among Children Living With HIV/AIDS

Role: collaborator

NCT05234112Not ApplicableCompleted

Prevention and Screening Towards Elimination of Cervical Cancer

Role: collaborator

NCT05291390Phase 2Unknown

Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

Role: collaborator

NCT04000503Not ApplicableCompleted

Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)

Role: collaborator

NCT02316444Phase 4Completed

Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda

Role: collaborator

NCT03542058Phase 3Unknown

Detecting and Treating Subclinical Anthracycline Therapy Related Cardiac Dysfunction in Low Income Country.

Role: collaborator

All 9 trials loaded